Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

422666

	registered interest
	date	20/10/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will take further steps to support Anthony Nolan's Destination Cure campaign.
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	uin	12658
	answer	answer is ministerial correction date of answer 28/10/2015 answer text <br /> <br /><p>Since 2011, the Department of Health has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><br /><p>The Government remains committed to improving stem cell transplantation services and doing all we can to help those in need of a transplant to find a suitable donor. The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan provides a timely contribution to this work.</p><br /> answering member constituency Battersea answering member printed Jane Ellison question first answered 28/10/2015 17:09:26 answering member 3918 label Biography information for Jane Ellison
	tabling member	4079 label Biography information for Julian Sturdy

514501

	registered interest
	date	20/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the post-treatment recovery package is adapted to meet the specific needs of blood cancer patients.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	34821
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The independent Cancer Taskforce published its report, <em>Achieving World Class Cancer Outcomes: A Strategy for England 2015-2020</em>, in July 2015, and recognised the need to improve care and support for people living with and beyond all types of cancer, including blood cancers. In September 2015, we announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016, we also published guidance for commissioners on commissioning and implementing the recovery package effectively. Support for patients living with and beyond cancer should be tailored specifically to the needs of every patient.</p><p> </p><p>In addition the strategy called for every person with cancer to have access to a clinical nurse specialist or other key worker from diagnosis onwards. NHS England is currently working with partners across the health system to determine how best to take forward the recommendations of the Cancer Taskforce, and has appointed Cally Palmer CBE as National Cancer Director. A National Cancer Transformation Board is overseeing the implementation of the strategy, and an implementation plan will be published shortly. An independent Cancer Advisory Group, chaired by Sir Harpal Kumar, the Chief Executive of Cancer Research UK and Chair of the independent Cancer Taskforce, is advising and scrutinising the work of the Transformation Board.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 34820 question first answered 28/04/2016 13:44:02 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

514500

	registered interest
	date	20/04/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that all blood cancer patients have access to a clinical nurse specialist or equivalent point of contact as part of their care.
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	uin	34820
	answer	answer is ministerial correction date of answer 28/04/2016 answer text <p>The independent Cancer Taskforce published its report, <em>Achieving World Class Cancer Outcomes: A Strategy for England 2015-2020</em>, in July 2015, and recognised the need to improve care and support for people living with and beyond all types of cancer, including blood cancers. In September 2015, we announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016, we also published guidance for commissioners on commissioning and implementing the recovery package effectively. Support for patients living with and beyond cancer should be tailored specifically to the needs of every patient.</p><p> </p><p>In addition the strategy called for every person with cancer to have access to a clinical nurse specialist or other key worker from diagnosis onwards. NHS England is currently working with partners across the health system to determine how best to take forward the recommendations of the Cancer Taskforce, and has appointed Cally Palmer CBE as National Cancer Director. A National Cancer Transformation Board is overseeing the implementation of the strategy, and an implementation plan will be published shortly. An independent Cancer Advisory Group, chaired by Sir Harpal Kumar, the Chief Executive of Cancer Research UK and Chair of the independent Cancer Taskforce, is advising and scrutinising the work of the Transformation Board.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 34821 question first answered 28/04/2016 13:44:02 answering member 3918 label Biography information for Jane Ellison
	tabling member	4131 label Biography information for Jim Shannon

353921

	registered interest
	date	12/06/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make an assessment of the implications for his policies of the recommendations in the report, Destination: Cure - arriving at a better future for people with blood cancer by Anthony Nolan; and if he will make a statement.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	2327
	answer	answer is ministerial correction date of answer 22/06/2015 answer text <p>Since 2011, the Department has provided our delivery partners, NHS Blood and Transplant and Anthony Nolan, a total of £16 million in additional, new funding to improve stem cell transplantation services in the United Kingdom. A further £3 million investment was announced in March 2015.</p><p> </p><p> </p><p> </p><p>This funding has led to a tangible improvement in the availability of stem cells in the UK and the achievements include:</p><p> </p><p> </p><p> </p><p>- More UK patients received a stem cell transplant in 2014 than ever before.</p><p> </p><p>- Over 60% of black, Asian and minority ethnic (BAME) patients are now able to find a well matched donor compared to only 40% in 2010.</p><p> </p><p>- A single unified bone marrow donor registry has been created streamlining the provision of stem cells and reducing the time to provide cells from adult donors.</p><p> </p><p>- The proportion of patients receiving cord blood from UK donors has significantly increased.</p><p> </p><p>- The increased use of UK-sourced stem cells has meant that more donors than ever are available to donate leading to a significant cost saving by reducing the need to import stem cells.</p><p> </p><p> </p><p> </p><p>The report ‘Destination Cure – arriving at a better future’ from Anthony Nolan is a timely contribution to the debate on the future of this work.</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 22/06/2015 16:15:58 answering member 3918 label Biography information for Jane Ellison
	tabling member	4126 label Biography information for Mary Glindon

528917

	registered interest
	date	27/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he has taken to adapt the cancer recovery package and investigate new models of care for blood cancer patients who are (a) given treatment and (b) put on a watch and wait regime after diagnosis.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	41329
	answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 41284 41285 question first answered 05/07/2016 15:11:22 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith

528908

	registered interest
	date	27/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients that understood the explanation given to them at diagnosis; and if he will take steps to increase support for such patients at the point of diagnosis.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	41285
	answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 41284 41329 question first answered 05/07/2016 15:11:22 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith

528906

	registered interest
	date	27/06/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Haematological Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what assessment he has made of the implications for his policies of the findings of the National Cancer Patient Experience Survey 2015 on the proportion of blood cancer patients who visited their GP more than twice before being referred to secondary care for diagnosis; and what support and guidance his Department has provided to GPs to enable them to identify the symptoms of blood cancer.
	tabling member constituency	Crawley
	tabling member printed	Henry Smith
	uin	41284
	answer	answer is ministerial correction date of answer 05/07/2016 answer text <p>It is important that people with cancer have the best possible experience throughout their cancer pathway and are treated with dignity and respect.</p><p> </p><p>The independent Cancer Taskforce published its report <em>Achieving World-Class Cancer Outcomes – A Strategy for England 2015-2020</em> in July 2015, and identified a key priority of establishing patient experience as being on a par with clinical effectiveness and safety. In May 2016 the National Cancer Transformation Board published <em>Achieving World-Class Cancer Outcomes:</em> <em>Taking the Strategy Forward</em> outlining the detailed steps being taken to make this a reality.</p><p> </p><p>In September 2015, the Government announced that by 2020, the 280,000 people diagnosed with cancer every year will benefit from a tailored recovery package. The packages will be individually designed to help each person, including those with blood cancer, live well beyond cancer. In April 2016 NHS England published guidance for commissioners on commissioning and implementing the recovery package effectively.</p><p> </p><p>In order to continue to support general practitioners (GPs) to identify patients whose symptoms may indicate cancer and urgently refer them as appropriate, the National Institute for Health and Care Excellence (NICE) published an updated suspected cancer referral guideline in June 2015. The guideline includes new recommendations for haematological cancers. NICE noted that more lives could be saved each year in England if GPs followed the new guideline, which encourages GPs to think of cancer sooner and lower the referral threshold. Following publication of the updated guideline, the Royal College of GPs (RCGP) has worked in collaboration with Cancer Research UK (CRUK) on a programme of regional update events for GPs to promote the new guideline. RCGP and CRUK have also worked to develop three summary referral guidelines for GPs to enable them to adopt the guideline. These are available at:</p><p> </p><p><a href="http://www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines" target="_blank">www.cancerresearchuk.org/health-professional/learning-and-development-tools/nice-cancer-referral-guidelines</a></p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 41285 41329 question first answered 05/07/2016 15:11:22 answering member 3918 label Biography information for Jane Ellison
	tabling member	3960 label Biography information for Henry Smith